BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 27091350)

  • 21. Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults.
    Lee JH; Shin JH; Roe IH; Sohn SG; Lee JH; Kang GH; Lee HK; Jeong BC; Lee SH
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1600-3. PubMed ID: 15793150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MOLECULAR DETECTION OF CLARITHROMYCIN AND FLUOROQUINOLONES RESISTANCE IN HELICOBACTER PYLORI INFECTION, DIRECTLY APPLIED TO GASTRIC BIOPSIES, IN AN URBAN BRAZILIAN POPULATION.
    Martins GM; Sanches BS; Moretzsohn LD; Lima KS; Cota BD; Coelho LG
    Arq Gastroenterol; 2016; 53(2):113-7. PubMed ID: 27305419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits.
    De Francesco V; Zullo A; Ierardi E; Giorgio F; Perna F; Hassan C; Morini S; Panella C; Vaira D
    J Antimicrob Chemother; 2010 Feb; 65(2):327-32. PubMed ID: 20008044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of clarithromycin resistance in Helicobacter pylori in Santiago, Chile, estimated by real-time PCR directly from gastric mucosa.
    Gonzalez-Hormazabal P; Musleh M; Escandar S; Valladares H; Lanzarini E; Castro VG; Jara L; Berger Z
    BMC Gastroenterol; 2018 Jun; 18(1):91. PubMed ID: 29925321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibiotic resistance in Helicobacter pylori and molecular methods for the detection of resistance].
    Demiray E; Yilmaz O
    Mikrobiyol Bul; 2005 Jul; 39(3):399-408. PubMed ID: 16358500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin.
    Furuta T; Soya Y; Sugimoto M; Shirai N; Nakamura A; Kodaira C; Nishino M; Okuda M; Okimoto T; Murakami K; Fujioka T; Hishida A
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1810-5. PubMed ID: 17914955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual-priming oligonucleotide-based multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens.
    Woo HY; Park DI; Park H; Kim MK; Kim DH; Kim IS; Kim YJ
    Helicobacter; 2009 Feb; 14(1):22-8. PubMed ID: 19191892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infections with
    Smith S; Fowora M; Pellicano R
    World J Gastroenterol; 2019 Jul; 25(25):3183-3195. PubMed ID: 31333310
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up.
    Raderer M; Wöhrer S; Kiesewetter B; Dolak W; Lagler H; Wotherspoon A; Muellauer L; Chott A
    Ann Hematol; 2015 Jun; 94(6):969-73. PubMed ID: 25579756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of clarithromycin-resistant Helicobacter pylori in patients with chronic tonsillitis by allele-specific Scorpion real-time polymerase chain reaction assay.
    Naserpour Farivar T; Najafipour R; Johari P
    Laryngoscope; 2013 Jun; 123(6):1478-82. PubMed ID: 23404672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori eradication rates in children upon susceptibility testing based on noninvasive stool polymerase chain reaction versus gastric tissue culture.
    Vécsei A; Innerhofer A; Graf U; Binder C; Giczi H; Hammer K; Bruckdorfer A; Hirschl AM; Makristathis A
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):65-70. PubMed ID: 21694538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antimicrobial susceptibility of Helicobacter pylori with chronic gastritis].
    Figueroa M; Cortés A; Pazos Á; Bravo LE
    Biomedica; 2012; 32(1):32-42. PubMed ID: 23235785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
    Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
    Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides.
    Kocsmár É; Buzás GM; Szirtes I; Kocsmár I; Kramer Z; Szijártó A; Fadgyas-Freyler P; Szénás K; Rugge M; Fassan M; Kiss A; Schaff Z; Röst G; Lotz G
    Nat Commun; 2021 Apr; 12(1):2255. PubMed ID: 33859206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of Helicobacter pylori and antimicrobial resistance in gastric biopsy specimens].
    Cağdaş U; Otağ F; Tezcan S; Sezgin O; Aslan G; Emekdaş G
    Mikrobiyol Bul; 2012 Jul; 46(3):398-409. PubMed ID: 22951652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
    Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
    Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Necessity of multiple gastric biopsies from different sites for detection of clarithromycin-resistant Helicobacter pylori strains.
    Masuda H; Hiyama T; Yoshihara M; Tanaka S; Shimamoto F; Haruma K; Chayama K
    Scand J Gastroenterol; 2003 Sep; 38(9):942-6. PubMed ID: 14531530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.